Rhythm Pharmaceuticals (RYTM) Retained Earnings (2016 - 2026)
Rhythm Pharmaceuticals (RYTM) reported Retained Earnings of -$1.4 billion for Q1 2026, down 16.2% year-over-year from -$1.7 billion in Q1 2025, and down 3.56% quarter-over-quarter from -$1.4 billion in Q4 2025.
Rhythm Pharmaceuticals (RYTM) Retained Earnings (2016 - 2026) Analysis & Trends
Rhythm Pharmaceuticals (RYTM) has 11 years of Retained Earnings data on file, last reported at -$1.4 billion in Q1 2026.
- Retained Earnings for Q1 2026 came in at -$1.4 billion, down 16.2% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.4 billion (down 16.2% YoY), and the FY2025 annual result was -$1.4 billion, down 17.01% from the prior year.
- Retained Earnings slipped to -$1.4 billion in Q1 2026 per RYTM's latest filing, from -$1.4 billion in the prior quarter.
- Over five years, Retained Earnings peaked at $134000.0 in Q4 2023 and troughed at -$1.4 billion in Q1 2026.
- A 5-year average of -$624.0 million and a median of -$626.7 million in 2022 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2023 and 2024: Retained Earnings jumped 245.65% in 2023, then plunged 7631107.14% in 2024.
- A 5-year view of Retained Earnings shows it stood at -$92000.0 in 2022, then jumped by 245.65% to $134000.0 in 2023, then plunged by 862292.54% to -$1.2 billion in 2024, then declined by 17.01% to -$1.4 billion in 2025, then retreated by 3.56% to -$1.4 billion in 2026.
- Business Quant data shows RYTM's Retained Earnings at -$1.4 billion in Q1 2026, -$1.4 billion in Q4 2025, and -$1.3 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 130.89 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -279.00 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -838.07 Mn |
| 10 | Rhythm Pharmaceuticals | 6.59 Bn | 6.25 Bn | 52.96 Mn | -1.40 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.40 Bn |
| Dec 31, 2025 | -1.35 Bn |
| Sep 30, 2025 | -1.30 Bn |
| Jun 30, 2025 | -1.25 Bn |
| Mar 31, 2025 | -1.20 Bn |
| Dec 31, 2024 | -1.16 Bn |
| Sep 30, 2024 | -604,000.00 |
| Jun 30, 2024 | -1.07 Bn |
| Mar 31, 2024 | -181,000.00 |
| Dec 31, 2023 | 134,000.00 |
| Sep 30, 2023 | -113,000.00 |
| Jun 30, 2023 | -14,000.00 |
| Mar 31, 2023 | -6,000.00 |
| Dec 31, 2022 | -92,000.00 |
| Sep 30, 2022 | -667.57 Mn |
| Jun 30, 2022 | -626.70 Mn |
| Mar 31, 2022 | -581.70 Mn |
| Dec 31, 2021 | -1,000.00 |
| Sep 30, 2021 | -486.07 Mn |
| Jun 30, 2021 | -450.97 Mn |